A Commentary to “The prevalence of hypertensive diseases and treated hypertensive patients in Japan: a nationwide administrative claims database study”

Sungha Park

doi:10.1038/s41440-022-00958-5

A Commentary to “The prevalence of hypertensive diseases and treated hypertensive patients in Japan: a nationwide administrative claims database study”

Sungha Park

Department of Internal Medicine

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1274-1275
Number of pages	2
Journal	Hypertension Research
Volume	45
Issue number	8
DOIs	https://doi.org/10.1038/s41440-022-00958-5
Publication status	Published - 2022 Aug

Bibliographical note

Funding Information:
SP does not have any direct conflict of interest with this study. However, SP has received honorarium from Pfizer, Beatrice, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, and Daewon. SP also has received research grant from Daiichi Sankyo.

All Science Journal Classification (ASJC) codes

Internal Medicine
Physiology
Cardiology and Cardiovascular Medicine

Access to Document

10.1038/s41440-022-00958-5

Cite this

@article{38db2864ee3049c28949731ff8835532,

title = "A Commentary to “The prevalence of hypertensive diseases and treated hypertensive patients in Japan: a nationwide administrative claims database study”",

author = "Sungha Park",

note = "Funding Information: SP does not have any direct conflict of interest with this study. However, SP has received honorarium from Pfizer, Beatrice, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, and Daewon. SP also has received research grant from Daiichi Sankyo. ",

year = "2022",

month = aug,

doi = "10.1038/s41440-022-00958-5",

language = "English",

volume = "45",

pages = "1274--1275",

journal = "Hypertension Research",

issn = "0916-9636",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - A Commentary to “The prevalence of hypertensive diseases and treated hypertensive patients in Japan

T2 - a nationwide administrative claims database study”

AU - Park, Sungha

N1 - Funding Information: SP does not have any direct conflict of interest with this study. However, SP has received honorarium from Pfizer, Beatrice, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, and Daewon. SP also has received research grant from Daiichi Sankyo.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85131696277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131696277&partnerID=8YFLogxK

U2 - 10.1038/s41440-022-00958-5

DO - 10.1038/s41440-022-00958-5

M3 - Comment/debate

C2 - 35689093

AN - SCOPUS:85131696277

SN - 0916-9636

VL - 45

SP - 1274

EP - 1275

JO - Hypertension Research

JF - Hypertension Research

IS - 8

ER -

A Commentary to “The prevalence of hypertensive diseases and treated hypertensive patients in Japan: a nationwide administrative claims database study”

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this